Skip to main content
. 2017 Apr 6;8(22):36484–36491. doi: 10.18632/oncotarget.16883

Figure 3.

Figure 3

mRNA expression of FGFR2 IIIC in PDCs from left and right metastatic lung lesions, respectively (A). Baseline osteopontin level and changes of osteopontin by fibroblast growth factor (FGF) in PDCs from left and right metastatic lung lesions, respectively (B).